You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clopidogrel

Showing 1 - 25 of 1,464
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metabolism of Clopidogrel Trial in Lancaster (Clopidogrel, Omeprazole/Clopidogrel)

Completed
Has Results
  • Metabolism of Clopidogrel
  • Lancaster, Pennsylvania
    Amish Research Clinic
Feb 21, 2022

Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Recruiting
  • Clopidogrel, Poor Metabolism of
  • Carotid Stenosis
  • San Donato Milanese, Milan, Italy
    IRCCS Policlinico San Donato
Sep 30, 2022

Severe Aortic Stenosis Trial in Seoul (Aspirin single antiplatelet therapy, Clopidogrel single antiplatelet therapy)

Not yet recruiting
  • Severe Aortic Stenosis
  • Aspirin single antiplatelet therapy
  • Clopidogrel single antiplatelet therapy
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 8, 2022

Coronary Artery Disease, Platelet Reactivity Trial in Nieuwegein (Clopidogrel)

Not yet recruiting
  • Coronary Artery Disease
  • Platelet Reactivity
  • Clopidogrel
  • Nieuwegein, Utrecht, Netherlands
  • +1 more
Dec 9, 2022

Ischemic Stroke Trial in Kafr Ash Shaykh (Ticagrelor 90 MG Oral Tablet, Clopidogrel tablet)

Recruiting
  • Ischemic Stroke
  • Ticagrelor 90 MG Oral Tablet
  • Clopidogrel tablet
  • Kafr Ash Shaykh, Egypt
    Kafr Elsheikh University Hospital
Nov 18, 2022

Bioequivalence Trial in Karachi (Clopid® 75 mg Tablet, Plavix® 75mg Tablet)

Completed
  • Bioequivalence
  • Clopid® 75 mg Tablet
  • Plavix® 75mg Tablet
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and Clinical Research (CBSCR)
Feb 14, 2022

Bleeding Complications Trial in Rochester (Clopidogrel, Prasugrel, Tricagrelor)

Recruiting
  • Bleeding Complications
  • Clopidogrel
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 30, 2022

Coronary Artery Disease Trial in Nanjing (Ticagrelor, Clopidogrel)

Withdrawn
  • Coronary Artery Disease
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Aug 18, 2021

Platelet Reactivity Trial in Harbin (Ticagrelor 90mg, Clopidogrel 75mg)

Completed
  • Platelet Reactivity
  • Ticagrelor 90mg
  • Clopidogrel 75mg
  • Harbin, Heilongjiang, China
    Thrombelastogram
Dec 20, 2021

Multi Vessel Coronary Artery Disease Trial in Seoul (Ticagrelor, Clopidogrel)

Not yet recruiting
  • Multi Vessel Coronary Artery Disease
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Dec 20, 2021

Platelet Reactivity Trial in Harbin (low-dose ticagrelor, Clopidogrel)

Completed
  • Platelet Reactivity
  • low-dose ticagrelor
  • Clopidogrel
  • Harbin, California, China
    VerifyNow
Dec 20, 2021

Acute Coronary Syndrome, Percutaneous Coronary Intervention Trial in Hangzhou (Standard-DAPT of Ticagrelor plus aspirin,

Not yet recruiting
  • Acute Coronary Syndrome
  • Percutaneous Coronary Intervention
  • Standard-DAPT of Ticagrelor plus aspirin
  • Sequential monotherapy of Ticagrelor and clopidogrel
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine at Zhejiang Universi
May 31, 2022

Intracranial Aneurysm Trial in Gyeonggi-do (Prasugrel group, Clopidogrel group)

Recruiting
  • Intracranial Aneurysm
  • Prasugrel group
  • Clopidogrel group
  • Gyeonggi-do, Yongin-si, Korea, Republic of
    Yongin Severance hospital, Yonsei university college of medicine
Jul 13, 2022

Clopidogrel Trial in Monastir (Platelet function assay)

Active, not recruiting
  • Clopidogrel
  • Platelet function assay
  • Monastir, Tunisia
    Fattouma Bourguiba Hospital
Sep 12, 2021

Myocardial Infarction, Thrombosis, Platelet Dysfunction Trial in Lancaster (Clopidogrel, Ticagrelor)

Recruiting
  • Myocardial Infarction
  • +2 more
  • Lancaster, Pennsylvania
    Amish Research Clinic
Jan 24, 2022

Acute Coronary Syndrome Trial (Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet)

Not yet recruiting
  • Acute Coronary Syndrome
  • Rivaroxaban 2.5 Mg Oral Tablet
  • +2 more
  • (no location specified)
Oct 5, 2022

Migraine Trial in Xi'an (clopidogrel)

Recruiting
  • Migraine
  • clopidogrel
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 23, 2021

Silent Brain Infarction Trial in Oklahoma City (Clopidogrel treatment, Aspirin treatment)

Recruiting
  • Silent Brain Infarction
  • Clopidogrel treatment
  • Aspirin treatment
  • Oklahoma City, Oklahoma
    Oklahoma City VA Medical Center, Oklahoma City, OK
Apr 1, 2022

Thrombosis Trial in Nanjing (Aspirin?clopidogrel? or SHR2285, Aspirin?ticagrelor? or SHR2285)

Active, not recruiting
  • Thrombosis
  • Aspirin、clopidogrel、placebo or SHR2285
  • Aspirin、ticagrelor、placebo or SHR2285
  • Nanjing, Jiangsu, China
    Nanjing Drum Tower Hospital
Oct 29, 2021

Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

Recruiting
  • Drug Resistance
  • additional blood sample
  • Paris, France
  • +3 more
Nov 12, 2021

Ischemic Heart Disease Trial in Seoul (Clopidogrel monotherapy, Aspirin monotherapy, zotarolimus-eluting stent (Resolute Onyx

Not yet recruiting
  • Ischemic Heart Disease
  • Clopidogrel monotherapy
  • +2 more
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Apr 8, 2022

Cerebral Aneurysm Trial in Paris (Clopidogrel, Ticagrelor, aspirin)

Completed
  • Cerebral Aneurysm
  • Clopidogrel
  • +2 more
  • Paris, France
    Fondation Ophtalmologique Adolphe de Rothschild
Jul 15, 2021

Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin

Withdrawn
  • Tracheostomy Complication
    • Columbus, Ohio
    • +1 more
    Nov 2, 2021

    Healthy Trial in Bad Krozingen (Cilostazol, Acetylsalicylic acid, Clopidogrel)

    Completed
    Has Results
    • Healthy
    • Bad Krozingen, Germany
      (unnamed)
    Sep 16, 2021

    Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor, Clopidogrel)

    Completed
    Has Results
    • Diabetes Mellitus, Type 2
    • Coronary Artery Disease
    • Jacksonville, Florida
      University of Florida
    Nov 2, 2021